185 related articles for article (PubMed ID: 12927853)
1. Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
Long YQ; Lung FD; Roller PP
Bioorg Med Chem; 2003 Sep; 11(18):3929-36. PubMed ID: 12927853
[TBL] [Abstract][Full Text] [Related]
2. Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
Long YQ; Guo R; Luo JH; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Oct; 310(2):334-40. PubMed ID: 14521914
[TBL] [Abstract][Full Text] [Related]
3. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
[TBL] [Abstract][Full Text] [Related]
4. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
5. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for Tyr in the consensus sequence Y-E-N of a novel nonphosphorylated inhibitor to the Grb2-SH2 domain.
Long YQ; Yao ZJ; Voigt JH; Lung FD; Luo JH; Burke TR; King CR; Yang D; Roller PP
Biochem Biophys Res Commun; 1999 Nov; 264(3):902-8. PubMed ID: 10544028
[TBL] [Abstract][Full Text] [Related]
7. Significant compensatory role of position Y-2 conferring high affinity to non-phosphorylated inhibitors of Grb2-SH2 domain.
Long YQ; Voigt JH; Lung FD; King CR; Roller PP
Bioorg Med Chem Lett; 1999 Aug; 9(15):2267-72. PubMed ID: 10465559
[TBL] [Abstract][Full Text] [Related]
8. Potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics.
Li P; Zhang M; Long YQ; Peach ML; Liu H; Yang D; Nicklaus M; Roller PP
Bioorg Med Chem Lett; 2003 Jul; 13(13):2173-7. PubMed ID: 12798329
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
[TBL] [Abstract][Full Text] [Related]
11. Discovery of thioether-bridged cyclic pentapeptides binding to Grb2-SH2 domain with high affinity.
Jiang S; Liao C; Bindu L; Yin B; Worthy KW; Fisher RJ; Burke TR; Nicklaus MC; Roller PP
Bioorg Med Chem Lett; 2009 May; 19(10):2693-8. PubMed ID: 19362470
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain.
Li P; Peach ML; Zhang M; Liu H; Yang D; Nicklaus M; Roller PP
Bioorg Med Chem Lett; 2003 Mar; 13(5):895-9. PubMed ID: 12617916
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics.
Jiang S; Li P; Peach ML; Bindu L; Worthy KW; Fisher RJ; Burke TR; Nicklaus M; Roller PP
Biochem Biophys Res Commun; 2006 Oct; 349(2):497-503. PubMed ID: 16945340
[TBL] [Abstract][Full Text] [Related]
14. N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding.
Burke TR; Yao ZJ; Gao Y; Wu JX; Zhu X; Luo JH; Guo R; Yang D
Bioorg Med Chem; 2001 Jun; 9(6):1439-45. PubMed ID: 11408162
[TBL] [Abstract][Full Text] [Related]
15. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides.
Lee K; Zhang M; Liu H; Yang D; Burke TR
J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226
[TBL] [Abstract][Full Text] [Related]
16. Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.
Oligino L; Lung FD; Sastry L; Bigelow J; Cao T; Curran M; Burke TR; Wang S; Krag D; Roller PP; King CR
J Biol Chem; 1997 Nov; 272(46):29046-52. PubMed ID: 9360978
[TBL] [Abstract][Full Text] [Related]
17. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
Song YL; Tan J; Luo XM; Long YQ
Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
19. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries.
Hart CP; Martin JE; Reed MA; Keval AA; Pustelnik MJ; Northrop JP; Patel DV; Grove JR
Cell Signal; 1999 Jun; 11(6):453-64. PubMed ID: 10400318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
